Back to Search Start Over

Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma.

Details

Language :
English
ISSN :
15228517
Volume :
23
Issue :
1
Database :
Complementary Index
Journal :
Neuro-Oncology
Publication Type :
Academic Journal
Accession number :
148453703
Full Text :
https://doi.org/10.1093/neuonc/noaa145